Compound having malate dehydrogenase inhibitory activity and pharmaceutical composition for preventing or treating cancer comprising same as active ingredient

A compound selected from the group consisting of the following compounds or a pharmaceutically acceptable salt thereof:

• (13) N-(4-(trifluoromethyl) phenyl)-2-(4-(2,4,4-trimethylpentan-2-yl) phenoxy) acetamide;
• (14) N-(4-(4-methylpiperazin-1-yl) phenyl)-2-(4-(2,4,4-trimethylpentan-2-yl) phenoxy) acetamide;
• (15) 1-(4-(4-(trifluoromethyl) benzyl) piperazin-1-yl)-2-(4-(2,4,4-trimethylpentan-2-yl) phenoxy) ethanone;
• (16) 1-(4-(prop-2-ynyl) piperazin-1-yl)-2-(4-(2,4,4-trimethylpentan-2-yl) phenoxy) ethanone;
• (17) Prop-2-ynyl 4-hydroxy-3-(2-(4-(2,4,4-trimethylpentan-2-yl) phenoxy) acetamido) benzoate;
• (24) methyl 4-methoxy-3-(2-(4-(2,4,4-trimethylpentan-2-yl) phenoxy) acetamido) benzoate:
• (53) N-(3-(Morpholine-4-carbonyl) phenyl)-3-(4-(2,4,4-trimethylpentan-2-yl) phenoxy) propanamide;
• (54) Ethyl 2-(3-(3-(4-(2,4,4-trimethylpentan-2-yl) phenoxy) propanamido) benzamido) acetate;
• and
• (55) (S)-methyl 3-methyl-2-(3-(3-(4-(2,4,4-trimethylpentan-2-yl) phenoxy) propanamido) benzamido) butanoate.